Reply to ‘The correlation between cotransplantation of mesenchymal stem cells and higher recurrence rates in hematologic malignancy patients: outcome of a pilot clinical study’ by Ning et al.-Reference-Cited by-同舟云学术

Reply to ‘The correlation between cotransplantation of mesenchymal stem cells and higher recurrence rates in hematologic malignancy patients: outcome of a pilot clinical study’ by Ning et al.

Published:2008-06-12 Issue:1 Volume:23 Page:178-178
ISSN:0887-6924
Container-title:Leukemia
language:en
Short-container-title:Leukemia

Author:

Behre G,Theurich S,Weber T,Christopeit M

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Cancer Research,Hematology

Link

http://www.nature.com/articles/leu2008150.pdf

Reference8 articles.

1. Ning H, Yang F, Jiang M, Hu L, Feng K, Zhang J et al. The correlation between cotransplantation of mesenchymal stem cells and higher recurrence rate in hematologic malignancy patients: outcome of a pilot clinical study. Leukemia 2008; 22: 593–599.

2. Vianello F, Dazzi F . Mesenchymal stem cells for graft-versus-host disease: a double edged sword? Leukemia 2008; 22: 463–465.

3. Bensinger WI, Martin PJ, Storer B, Clift R, Forman SJ, Negrin R et al. Transplantation of bone marrow as compared with peripheral-blood cells from HLA-identical relatives in patients with hematologic cancers. N Engl J Med 2001; 344: 175–181.

4. Klumpp TR . Hematopoietic reconstitution by transplantation of stem cells from bone marrow or blood. N Engl J Med 2001; 344: 1641; author reply 2001; 344:1641–1642.

5. Schoch C, Haferlach T, Haase D, Fonatsch C, Loffler H, Schlegelberger B et al. Patients with de novo acute myeloid leukaemia and complex karyotype aberrations show a poor prognosis despite intensive treatment: a study of 90 patients. Br J Haematol 2001; 112: 118–126.

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Therapeutic Purposes and Risks of Ex Vivo Expanded Mesenchymal Stem/Stromal Cells;Mesenchymal Stromal Cells as Tumor Stromal Modulators;2017

2. The potential of cytotherapeutics in hematologic reconstitution and in the treatment and prophylaxis of graft-versus-host disease. Chapter II: emerging transformational cytotherapies;Regenerative Medicine;2015-05

3. Bone Marrow Mesenchymal Stromal Cells to Treat Complications Following Allogeneic Stem Cell Transplantation;Tissue Engineering Part B: Reviews;2014-06

4. Mesenchymal Stem Cells as Cellular Immunotherapeutics in Allogeneic Hematopoietic Stem Cell Transplantation;Mesenchymal Stem Cells - Basics and Clinical Application II;2013

5. Safety Issues in MSC Therapy;Mesenchymal Stromal Cells;2012-12-04